Evidence map›Paper›PMID 41822933›Full record

ArticleFrontiers in public health2026

Investigating the population health impact of an oral tobacco-derived nicotine pouch product utilizing a three-product tobacco use population model.

Raheema Muhammad-Kah, Thaddaeus Hannel, Lai Wei, Hui Cheng, Sucharitha Iyer, Mohamadi Sarkar

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raheema Muhammad-KahCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Thaddaeus HannelCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Lai WeiCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Hui ChengCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Sucharitha IyerCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.
Mohamadi SarkarCenter for Research and Technology, Altria Client Services LLC, Richmond, VA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study employed a three-product agent-based model (ABM) to evaluate the potential population-level effects of granting market authorization for Methods: Developed in MATLAB Results: Model outputs indicated that introducing the Test Product could prevent approximately 476,000 premature deaths, reduce cigarette prevalence by 0.6 percentage points, and ST product use by 0.3 percentage points, while increasing Test Product use by 1.6 percentage points. Conclusion: These findings suggest that regulatory authorization of

Indexed as

NicotinePopulation HealthTobacco ProductsTobacco, SmokelessTobacco UseHumansNicotineagent-based modelingmortality estimatesnicotine pouchesoral tobacco-derived nicotinepopulation healththree-product population modeling

Identifiers

PMID41822933
PMCPMC12975934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.